MED-EL acquires BHM-Tech to further strengthen its expertise in innovative hearing solutions 

MED-EL, a global leader in hearing implant solutions, is excited to announce the acquisition of Austrian BHM-Tech Ltd., which took place in July 2024. A renowned expert for bone conduction hearing systems, BHM-Tech, headquartered in Grafenschachen (Burgenland, Austria), offers innovative solutions for people with hearing loss. The acquisition further strengthens MED-EL’s position in the hearing solutions sector, broadening its product portfolio with sophisticated bone conduction technologies. It also emphasizes MED-EL’s commitment to continuously developing and offering innovative, high-quality hearing solutions designed to enhance the quality of life for people with hearing loss.

Seamless transition
After the successful handover of his company, BHM founder Franz Berl will retire. To ensure a smooth transition, he will continue to offer his know-how as a consultant. Markus Hütter, an experienced MED-EL employee for many years, was appointed as the new CEO for BHM-Tech. “We look forward to integrating BHM-Tech’s innovative product portfolio into the MED-EL family”, Hütter says. “Together, we will further advance the future of hearing technology and continue to offer first-class hearing solutions to our customers.” All BHM-Tech employees will stay in their positions and continue working in their familiar surroundings. This underlines MED-EL’s commitment to continuity and the advancement of innovative technologies and its appreciation for the BHM-Tech team’s expertise. 

 Combined know-how
The acquisition helps MED-EL meet the needs of people with hearing loss even better, as BHM-Tech’s cutting-edge bone conduction technology provides additional options. With its comprehensive know-how and international network, BHM-Tech will continue to advance innovations in its specialised field. Both MED-EL and BHM-Tech welcome the combination of two Austrian companies with a long-standing tradition and emphasize their joint efforts to advance and improve hearing solutions globally. Financial details on the acquisition are confidential and will not be disclosed by either party.